RAFFA, Robert B.; PORRECA, Frank. Thermodynamic analysis of the drug-receptor interaction. Life Sciences. 1989-01-01, roč. 44, čís. 4, s. 245–258. Dostupné online [cit. 2021-02-05]. ISSN0024-3205. DOI10.1016/0024-3205(89)90182-3. (anglicky)
MOY, V.; FLORIN, E.; GAUB, H. Intermolecular forces and energies between ligands and receptors. Science. 1994-10-14, roč. 266, čís. 5183, s. 257–259. Dostupné online [cit. 2021-02-05]. ISSN0036-8075. DOI10.1126/science.7939660. (anglicky)
OVERINGTON, John P.; AL-LAZIKANI, Bissan; HOPKINS, Andrew L. How many drug targets are there?. Nature Reviews Drug Discovery. 2006-12, roč. 5, čís. 12, s. 993–996. Dostupné online [cit. 2021-02-05]. ISSN1474-1776. DOI10.1038/nrd2199. (anglicky)
DIXON, Scott J; STOCKWELL, Brent R. Identifying druggable disease-modifying gene products. Current Opinion in Chemical Biology. 2009-12, roč. 13, čís. 5–6, s. 549–555. Dostupné online [cit. 2021-02-05]. DOI10.1016/j.cbpa.2009.08.003. PMID19740696. (anglicky)
DIXON, Scott J; STOCKWELL, Brent R. Identifying druggable disease-modifying gene products. Current Opinion in Chemical Biology. 2009-12, roč. 13, čís. 5–6, s. 549–555. Dostupné online [cit. 2021-02-05]. DOI10.1016/j.cbpa.2009.08.003. PMID19740696. (anglicky)
nature.com
OVERINGTON, John P.; AL-LAZIKANI, Bissan; HOPKINS, Andrew L. How many drug targets are there?. Nature Reviews Drug Discovery. 2006-12, roč. 5, čís. 12, s. 993–996. Dostupné online [cit. 2021-02-05]. ISSN1474-1776. DOI10.1038/nrd2199. (anglicky)
DIXON, Scott J; STOCKWELL, Brent R. Identifying druggable disease-modifying gene products. Current Opinion in Chemical Biology. 2009-12, roč. 13, čís. 5–6, s. 549–555. Dostupné online [cit. 2021-02-05]. DOI10.1016/j.cbpa.2009.08.003. PMID19740696. (anglicky)
OVERINGTON, John P.; AL-LAZIKANI, Bissan; HOPKINS, Andrew L. How many drug targets are there?. Nature Reviews Drug Discovery. 2006-12, roč. 5, čís. 12, s. 993–996. Dostupné online [cit. 2021-02-05]. ISSN1474-1776. DOI10.1038/nrd2199. (anglicky)